Navigation Links
Martin Madaus Joins Mettler Toledo Board of Directors
Date:6/22/2009

COLUMBUS, Ohio, June 22 /PRNewswire-FirstCall/ -- Mettler-Toledo International Inc. (NYSE: MTD) announced today that Dr. Martin D. Madaus has been appointed to its Board of Directors, effective July 1, 2009.

Dr. Madaus is Chairman, President and Chief Executive Officer of Millipore Corporation (NYSE: MIL), a life sciences company serving the bioscience research and biopharmaceutical manufacturing industry. Prior to joining Millipore in 2005, he was at Roche Diagnostics Corporation where, as President and Chief Executive Officer, he was responsible for the North American operations.

Robert F. Spoerry, Chairman of the Board, stated, "Martin brings very relevant experience to our Board. His background and insights into the life sciences market will be invaluable, as this market is an important area of growth for us. Martin has an excellent leadership track record, both in developing effective strategies and in achieving results. We welcome him and look forward to a close collaboration."

METTLER TOLEDO is a leading global supplier of precision instruments and services. The Company is the world's largest manufacturer and marketer of weighing instruments for use in laboratory, industrial and food retailing applications. The Company also holds top-three market positions in several related analytical instruments and is a leading provider of automated chemistry systems used in drug and chemical compound discovery and development. In addition, the Company is the world's largest supplier of metal detection and other end-of-line inspection systems used in production and packaging and holds a leading position in certain process analytics applications. Additional information about METTLER TOLEDO can be found at "www.mt.com."

Statements in this discussion which are not historical facts may be considered "forward-looking statements" that involve risks and uncertainties. For a discussion of these risks and uncertainties, which could cause actual events or results to differ from those contained in the forward-looking statements, see "Factors affecting our future operating results" in Part I, Item 1A, of the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2008. The Company assumes no obligation to update this press release.


'/>"/>
SOURCE Mettler-Toledo International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Prestwick Pharmaceuticals, Inc. Continues to Build Management Team With Appointment of Martin Stogniew, Ph.D. as Executive Vice President, Chief Technology Officer
2. Meredith Martin Addy Named Chair of AIPLAs Amicus Committee
3. Meredith Martin Addy Named One of Top 10 Illinois Super Lawyers for 2008
4. Galil Medical Announces the Appointment of Martin J. Emerson as President and Chief Executive Officer
5. Metabolex Names Zhao, Martin to Executive Posts
6. Lockheed Martin Invests in Smart Grid Research and Development at Penn State University
7. InspireMD Announce the Completion of Enrollment for the MAGICAL Trial (MGuard(TM) in Acute Myocardial Infarction) at EuroPCR 09. Results Will be Presented May 21st by Dr. Dariusz Dudek at the InspireMD Cocktail Reception Debate Chaired by Prof. Martin Le
8. Roche Joins Forces With Enon Tabernacle Baptist Church to Provide Free Hepatitis C Testing to the Community
9. Ralf Rosskamp, M.D. Joins Biodels Scientific Advisory Board
10. Hank Plain Joins Morgenthaler Ventures as Partner
11. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- Houston Methodist Willowbrook Hospital has signed a ... serve as their official health care provider. As ... provide sponsorship support, athletic training services, and most ... athletes and families. "We are excited ... to bring Houston Methodist quality services and programs ...
(Date:6/23/2016)... 23, 2016   EpiBiome , a precision microbiome ... in debt financing from Silicon Valley Bank (SVB). The ... to advance its drug development efforts, as well as ... "SVB has been an incredible strategic partner to ... traditional bank would provide," said Dr. Aeron Tynes ...
(Date:6/23/2016)... , June 23, 2016 Apellis Pharmaceuticals, ... 1 clinical trials of its complement C3 inhibitor, ... and multiple ascending dose studies designed to assess ... of subcutaneous injection in healthy adult volunteers. ... either as a single dose (ranging from 45 ...
(Date:6/23/2016)... CA (PRWEB) , ... June 23, 2016 , ... ... software, is exhibiting at the Pennsylvania Convention Center and will showcase its product’s ... conference. ClinCapture will also be presenting a scientific poster on Disrupting Clinical Trials ...
Breaking Biology Technology:
(Date:5/24/2016)... , May 24, 2016 Ampronix facilitates superior patient care by providing ...  3D medical LCD display is the latest premium product recently added to the range ... ... ... Sony 3d Imaging- LCD Medical Display- Ampronix News ...
(Date:5/9/2016)... DUBAI , UAE, May 9, 2016 ... choice when it comes to expanding freedom for high ... Even in today,s globally connected world, there ... online conferencing system could ever duplicate sealing your deal ... are obtaining second passports by taking advantage of citizenship ...
(Date:4/26/2016)... and LONDON , April 26, ... of EdgeVerve Systems, a product subsidiary of Infosys ... announced a partnership to integrate the Onegini mobile ...      (Logo: http://photos.prnewswire.com/prnh/20151104/283829LOGO ) ... customers enhanced security to access and transact across ...
Breaking Biology News(10 mins):